Matrilin-2 with a K-Chitosan Scaffold Enhances Functional Recovery and Nerve Regeneration in a Segmental Rat Sciatic Nerve Injury Model

Neill Y. Li, Brandon Vorrius, Elliott Rebello, Jonathan Ge, A. S. Mohite, Zhen Qiao, Jing Ding, Qian ChenPharmaceuticals 2025 · DOI

TL;DR

Researchers have developed a novel biomimetic scaffold using Matrilin-2 and lysine-modified chitosan (K-chitosan) that significantly enhances functional recovery and nerve regeneration in rats with sciatic nerve injuries. This scaffold shows comparable results to traditional autografts, offering a promising alternative for treating peripheral nerve damage.

What Problem Does This Paper Address?

Peripheral nerve injuries (PNIs) are a significant health concern, affecting millions and leading to substantial healthcare costs. Despite current repair methods like conduits, allografts, and autografts, functional recovery remains poor, with less than 50% of patients regaining full motor and sensory function. Existing solutions have limitations: conduits are best for small gaps, allografts lose crucial regenerative factors during processing, and autografts require a donor site, introducing risks like hematoma, infection, and neuroma formation. This paper addresses the need for innovative, off-the-shelf solutions that can bridge larger nerve gaps, promote robust regeneration, and minimize donor site morbidity.

Methods

The study employed a rat sciatic nerve injury model to compare three treatment groups:

  • Untreated Collagen Conduit (UC): A standard collagen conduit without any added regenerative factors.
  • Treated Conduit (TC): A collagen conduit incorporating a novel 3D scaffold made of lysine-modified chitosan (K-chitosan) decorated with Matrilin-2 (MATN2).
  • Reverse Autograft (RA): A traditional nerve autograft, serving as a positive control.

Functional recovery was assessed using:

  • Walking Track Gait Analysis: To measure paw pressure and weight distribution on the injured hindlimb.
  • Compound Muscle Action Potential (CMAP): To evaluate nerve conduction and muscle activation.
  • Muscle Weights: To quantify denervation atrophy in the tibialis anterior and gastrocnemius muscles.

Histological analysis included:

  • Axon Quantification: Using toluidine blue staining to count regenerated axons in the distal nerve stump.
  • Schwann Cell Immunofluorescence: To assess the presence, distribution, and clustering of Schwann cells (SCs) within the reconstructed nerve segments.

Datasets

Not discussed in the paper. The study utilized a rat model for its experiments.

Key Insights and Ideas

  • MATN2 and K-chitosan Synergy: The combination of Matrilin-2 (a protein known to promote SC migration and axonal outgrowth) with lysine-modified chitosan (K-chitosan) creates a biomimetic scaffold that actively supports nerve regeneration.
  • Enhanced SC Behavior: The MATN2/K-chitosan scaffold significantly increased Schwann cell counts and promoted better clustering and propagation, suggesting a more favorable microenvironment for nerve repair.
  • Bridging the Gap: The scaffold's multi-channel architecture appears to effectively guide SC migration and axonal regeneration across the nerve defect, outperforming a simple hollow conduit.
  • Autograft-like Performance: Remarkably, the treated conduit (TC) group achieved functional and histological outcomes comparable to the reverse autograft (RA) group, highlighting its potential as a viable alternative.

Key Results

  • Functional Recovery: The TC group showed significantly improved walking force and CMAP recovery compared to the UC group. Importantly, the TC group's performance was comparable to the RA group for both measures.
  • Muscle Preservation: Muscle atrophy was significantly reduced in the TC group compared to the UC group. While the RA group showed the most muscle preservation, the TC group still demonstrated substantial improvement over the untreated conduit.
  • Axonal Regeneration: The TC group exhibited significantly more regenerated axons than the UC group, with no significant difference compared to the RA group.
  • Schwann Cell Distribution: Immunofluorescence revealed greater SC presence and more organized distribution in the TC group compared to the UC group, with similar patterns observed between the TC and RA groups.

Limitations and Future Work

The authors acknowledge a primary limitation: the study was conducted over a 12-week period. They suggest that future research should extend to longer-term assessments (one to two years) to fully understand the scaffold's long-term impact. Additionally, further studies are recommended to:

  • Investigate the immune response in more detail, analyzing the presence and behavior of various immune cells (macrophages, fibroblasts, T-cells) and their associated signaling molecules.
  • Further explore the differences in neuromuscular junction morphology and neurofilament interactions.
  • Elucidate the precise mechanistic and immune-related differences when using this combined MATN2 and K-chitosan scaffold.

Summary updated

Abstract

<b>Background/Objectives:</b> Previous work in our lab demonstrated that a 3D scaffold containing lysine-modified chitosan (K-chitosan) and decorated with Matrilin-2 (MATN2) enhanced Schwann cell (SC) migration and axonal outgrowth in vitro and ex vivo. This study aimed to assess the regenerative effect of this scaffold compared to that of a collagen conduit and an autograft using a segmental rat sciatic nerve injury model. <b>Methods:</b> A total of 30 Lewis Rats were assigned into three groups: an untreated collagen conduit (UC) group, a collagen conduit treated with MATN2 K-chitosan (TC) group, and a reverse autograft (RA) group. Walking force measurements, compound muscle action potential (CMAP), the wet muscle weight of the tibialis anterior and the gastrocnemius, and axonal histomorphometry were assessed. <b>Results:</b> The walking force and CMAP were significantly higher in the TC group compared to those in the UC group, with no significant difference between the TC and RA groups. The muscle weights were significantly greater in the TC group compared to those in the UC group but smaller than those in the RA group. The TC group experienced significantly greater axonal regeneration compared to that with the UC, and no differences were found with the RA. The TC group further demonstrated significantly greater cell counts than those in the UC group and greater affinity of the Schwann cells towards nerve reconstruction. <b>Conclusion:</b> The MATN2 K-chitosan scaffold significantly improved nerve regeneration and was comparable to the RA, supporting the development of a novel bio-conductive scaffold conduit.
BibTeX
@inproceedings{li2025matrilin,
  author = {Neill Y. Li and Brandon Vorrius and Elliott Rebello and Jonathan Ge and A. S. Mohite and Zhen Qiao and Jing Ding and Qian Chen},
  title = {{Matrilin-2 with a K-Chitosan Scaffold Enhances Functional Recovery and Nerve Regeneration in a Segmental Rat Sciatic Nerve Injury Model}},
  booktitle = {Pharmaceuticals},
  year = {2025},
  doi = {10.3390/ph18050686},
}
Figure